Business Wire

NJ-FREYR-SOLUTIONS

13.8.2024 07:50:33 CEST | Business Wire | Press release

Share
Freyr Recognized as a Leader in Everest Group PEAK Matrix® 2024

Freyr, a premier global Regulatory solutions and services provider, proudly announces its distinguished placement as a Leader in the esteemed Everest Group Life Sciences Regulatory and Medical Affairs Operations PEAK Matrix® Assessment 2024. Freyr has emerged as the leader from this comprehensive evaluation of over twenty (20) global service providers.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240731962821/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Everest Group Life Sciences and Medical Affairs Operations PEAK Matrix® Assessment 2024 (Graphic: Business Wire)

The PEAK Matrix® offers an impartial, data-driven evaluation of service and technology providers, categorizing them as Leaders, Major Contenders, or Aspirants based on their overall capabilities and market impact.

“In the rapidly evolving regulatory landscape, enterprises face a myriad of challenges, such as navigating complex compliance frameworks, ever-changing regulations, and diverse geographical needs. Consequently, enterprises are increasingly reliant on external service providers with specialized knowledge and technological expertise to manage these complexities," says Lloyd Fernandes, Practice Director at Everest Group. He added, "Freyr's extensive market presence and robust affiliate network, bolstered by its localized expertise, make it adept at navigating diverse regulatory environments. Furthermore, its comprehensive portfolio of technological solutions built on the AI first Freya Fusion platform, along with its dedicated centers of excellence, enable it to effectively address clients' digitization and efficiency demands. These strengths have contributed to its Leader positioning in Everest Group's Regulatory and Medical Affairs Operations PEAK Matrix Assessment 2024."

Suren Dheenadayaalan, CEO of Freyr Solutions, expressed his delight, stating, "Securing the Leader position in the Everest Group Life Sciences Regulatory and Medical Affairs Operations PEAK Matrix® Assessment is a significant milestone for Freyr. This recognition reaffirms our commitment throughout the Regulatory value chain in the Life Sciences sector. We take pride in being recognized as a reliable global Regulatory partner and remain committed to fostering innovation while surpassing compliance standards in the intricate Regulatory landscape."

Rajiv Rangan, Co-founder of Freyr Solutions, added, "This acknowledgment from the prestigious Everest Group underscores our continued dedication to Regulatory services & solution excellence spanning over decade+ years. On behalf of the founding team of Freyr, I extend our sincere and heartfelt gratitude to our global colleagues and customers for their continued and invaluable support, without which this accomplishment would not have been possible."

About Freyr

Freyr Solutions provides global Regulatory solutions, with 2100+ experts supporting 1550+ customers in 120+ countries.

"Discover how Freyr leads the way in regulatory excellence—visit our website for more details. Freyr Solutions"

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240731962821/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Croma-Pharma Announces FDA Approval of Obagi saypha® ChIQ™ in the United States1.7.2026 12:34:00 CEST | Press release

ChIQ™ becomes the second FDA-approved product from Croma's saypha® portfolio in the U.S., expanding treatment options for facial volume restoration. Wrapping up the first half of 2026 with another important milestone, Croma-Pharma announces the FDA approval of Obagi saypha® ChIQ™ in the United States. Obagi saypha® ChIQ™ injectable hyaluronic acid gel is approved for cheek augmentation and correction of midface contour deficiencies in adults over the age of 21. Developed and manufactured by Croma-Pharma and commercialized by Obagi Medical, a Waldencast company, in the U.S., ChIQ™ follows the approval of Obagi saypha® MagIQ™ in September 2025 and further broadens the availability of Croma's injectable aesthetic solutions in the United States. As demand for minimally invasive aesthetic treatments continues to grow, the approval broadens the range of treatment options available to healthcare professionals and patients seeking safe and natural-looking aesthetic outcomes. "With the approval

Rezon Bio Appoints Dr. Hubert Scholze as Chief Business Officer to Accelerate Global Commercial Expansion1.7.2026 12:01:00 CEST | Press release

Rezon Bio, a science-driven European biologics contract development and manufacturing organization (CDMO), today announced the appointment of Dr. Hubert Scholze as Chief Business Officer (CBO), effective July 1, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260701630118/en/ Dr. Hubert Scholze, Chief Business Officer, Rezon Bio As a member of Rezon Bio’s Executive Leadership Team, Dr. Hubert Scholze will lead the company’s commercial functions, overseeing Business Development, Market Intelligence, Global Marketing, Proposal Management and Project Management. Hubert Scholze, PhD will be responsible for Rezon Bio’s commercial strategy, strengthening strategic partnerships, supporting the company’s continued international growth, and ensuring a seamless client experience from initial engagement to program execution. His appointment comes at pivotal moment for Rezon Bio as the company continues to strengthen its integrated

CoStar Group Invests in Wikicasa, Italy’s Agent-Backed Real Estate Marketplace1.7.2026 12:00:00 CEST | Press release

Transaction will result in an approximately 30% stake in the company and support innovation and digital transformation in the Italian real estate market CoStar Group, Inc. (NASDAQ: CSGP), a global leader in online real estate marketplaces, information, analytics and 3D digital twin technology in the property markets, today announced an investment in Wikicasa, Italy’s agent-backed real estate marketplace. The transaction will result in CoStar Group acquiring an approximately 30% stake in Wikicasa. Wikicasa’s shareholder base includes Italy’s leading real estate agencies - including Tecnocasa Group, Gabetti Group, RE/MAX Italy, and Tempocasa. Wikicasa.it is an agent-driven platform that brings together leading real estate professionals across Italy to deliver a high-quality, data-rich marketplace of over 600,000 listings, more than 100,000 of which are commercial. It provides consumers with comprehensive property listings while equipping agents with modern data and intelligence tools to

Forrester Announces The Conference Agenda For B2B Forum EMEA 20261.7.2026 11:46:00 CEST | Press release

The event will help B2B leaders modernise their go-to-market strategies to navigate AI-enabled buyer autonomy Forrester (Nasdaq: FORR) today announced the full conference agenda for its B2B Forum EMEA 2026, taking place 28–29 September 2026 in London. Centered on the theme, “Hello, GTM Singularity,” the event will bring together marketing, sales, product, customer success, and revenue leaders to address the collapse of traditional go-to-market (GTM) models. According to Forrester, approximately nine in 10 business buyers now use genAI or conversational search in the buying process. As AI-led discovery, changing buying behaviours, and increasingly complex buying networks continue to disrupt how customers discover, evaluate, and purchase solutions, organisations must integrate their GTM approach as a unified system that builds visibility, preference, and trust. Designed as an intimate event for senior B2B leaders, B2B Forum EMEA 2026 will combine keynote presentations, analyst-led sessio

Ant International Unveils Global Development Centre in Malaysia, Expanding Commitment to AI, Talent, Trust and Digital Innovation1.7.2026 11:06:00 CEST | Press release

Ant International is developing around 1,500 talents in Kuala Lumpur, with more than half in tech-related roles, supporting the company’s global innovations and business growthSpending by Alipay+ partners via the DuitNow national QR increased more than 60%, driving travel-led economic impact as the country celebrates Visit Malaysia 2026Since launching in January 2026 with TNG Digital, Ant International’s EPOS360 AI-as-a-Service platform now supports more than 14,000 Malaysian SMEs Ant International today officially opened its Global Development Centre (GDC) in Kuala Lumpur, deepening its long-term commitment to Malaysia and Southeast Asia, and strengthening the country's role as a strategic hub for global innovation, digital talent, and next-generation financial technology. The unveiling ceremony was officiated by the Prime Minister of Malaysia, YAB Dato' Seri Anwar Ibrahim. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye